agglutinogen

WordNet

Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis.

Bock JM1, Burtis CC, Poetker DM, Blumin JH, Frank MO.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.Otolaryngol Head Neck Surg.2012 Jan;146(1):63-7. doi: 10.1177/0194599811425145. Epub 2011 Oct 10.
OBJECTIVES: Incidence of Bordetella pertussis infection among adults has risen significantly throughout the United States, but pertussis is not often considered in the differential diagnosis of chronic cough in adults. The authors hypothesized that serum IgG testing can establish a diagnosis of pert
PMID 21987649

Basnak'ian IA, Aleksakhina NN, Shelemekh OV, Miriasova LV, Siundiukova RA.
Zhurnal mikrobiologii, epidemiologii, i immunobiologii.Zh Mikrobiol Epidemiol Immunobiol.2007 May-Jun;(3):37-42.
Bordetella pertussis growth phases during homogenous batch dynamic cultivation in the liquid medium as well as during the static cultivation on the solid medium were established. The maximal activity of agglutination reaction with antisera to B. pertussis agglutinogens 1, 2, and 3 was detected in ba
PMID 17672129

Corvelo TC1, Schneider H, Harada ML.
Journal of medical primatology.J Med Primatol.2002 Jun;31(3):136-41.
The ABO blood groups were determined in blood and saliva collected from 40 Aotus infulatus, 74 Saimiri sciureus, and 96 Cebus apella from the Amazonian region along the Tocantins river. Saliva samples were tested for human ABH antigens by a standard hemagglutination inhibition test. Aotus infulatus
PMID 12190854

Agglutionogens and Fimbriae of Bordetella pertussis(I. Characterization of Virulence Factors of Bordetella pertussis)(Current Studies on Future Vaccines)

ASHWORTH L. A. E.,ROBINSON A.,FUNNELL S.,GORRINGE A. R.,IRONS L. I.,SEABROOK R. N.
Tokai journal of experimental and clinical medicine 13(Supplement), 203-210, 1988-09-22
… Agglutinogen 2 (AGG2) of Bordetella pertussis is a fimbrial antigen and therefore a potential adhesin and acellular vaccine component. …
NAID 110004700516

The Current Epidemiology of Pertussis in the Developed World : UK and West Germany(A. Current Epidemiology of Pertussis)(II. The Eradication of Pertussis: Current Unsolved Epidemiologic, Clinical and Public Health Problems which Impede This Goal)(Clinical Aspects of Acellular Pertussis Vaccines)

MILLER Elizabeth,FARRINGTON Conor P.
Tokai journal of experimental and clinical medicine 13(Supplement), 97-101, 1988-09-22
… However, there is evidence that the current whole cell vaccine may protect less well against infection with agglutinogen serotype 3 than type 2 organisms which supports the view that both these antigens should be included in acellular vaccines to achieve good protection. …
NAID 110004700499

Overview of Currently Available Japanese Acellular Pertussis Vaccines and Future Problems(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)

KAMIYA Hitoshi,NII Ritsue
Tokai journal of experimental and clinical medicine 13(Supplement), 45-49, 1988-09-22
… This vaccine contains pertussis toxin (PT), filamentous hemagglutinin (FHA) and agglutinogen (AGG) as the main protective antigens. …
NAID 110004700491